Dendritic Cell Based Therapy of Renal Cell Carcinoma

NCT00197860 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
40
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Inge Marie Svane